Home Newsfeeds UBS Downgrades Intact Financial to Neutral

UBS Downgrades Intact Financial to Neutral

UBS analyst Brian Meredith downgrades Intact Financial (OTC:IFCZF) from Buy to Neutral.

byBenzinga Newsdesk

October 12, 2022

1 minute read

UBS analyst Brian Meredith downgrades Intact Financial (OTC:IFCZF) from Buy to Neutral.

DA Davidson Maintains Buy on Beauty Health, Raises Price Target to $31

By Benzinga Newsdesk

September 28, 4:44 AM

DA Davidson analyst Linda Bolton Weiser maintains Beauty Health (NASDAQ:SKIN) with a Buy and raises the price target from $30 to $31.

SKIN

Top 4 Health Care Stocks That Are Preparing To Pump This Quarter

By Lisa Levin

October 6, 8:26 AM

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

CUTR

Where To Buy Martha Stewart’s New CBD Gummies? New Flavor Hits Shelves Under Partnership With Canopy Growth

By Jelena Martinovic

August 15, 10:57 AM

Martha Stewart CBD has unveiled the latest flavor in its CBD portfolio – Pumpkin Spice CBD Wellness Gummies. The new flavor is a part of Martha's continued partnership with Canadian cannabis giant Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC).

CGC

Telsey Advisory Group Reiterates Outperform on European Wax Center, Maintains $22 Price Target

By Benzinga Newsdesk

March 10, 6:22 AM

Telsey Advisory Group analyst Dana Telsey reiterates European Wax Center (NASDAQ:EWCZ) with a Outperform and maintains $22 price target.

EWCZ

UBS Downgrades Intact Financial to Neutral

Related Posts

DA Davidson Maintains Buy on Beauty Health, Raises Price Target to $31

Top 4 Health Care Stocks That Are Preparing To Pump This Quarter

Where To Buy Martha Stewart’s New CBD Gummies? New Flavor Hits Shelves Under Partnership With Canopy Growth

Telsey Advisory Group Reiterates Outperform on European Wax Center, Maintains $22 Price Target